Transaction · 0001685720-26-000003
EBSEmergent BioSolutions Inc.
Zoon Kathryn C
Zoon Kathryn C, DIR, reported a transaction classified as grant at Emergent BioSolutions Inc. involving 11296.000000 shares for an estimated $0.00. Reported holdings after the transaction were 11296.000000 shares. The stored filing text includes a detected 10b5-1 reference.
grantSEC transaction code ADIR
- Trade date
- Apr 30, 2026
- Filing date
- May 04, 2026
How reported position traded is calculated
Not calculated for derivative securities.
Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.
EBS price since this filing
Daily closing prices, with the filing date and available return windowsEBS · Daily closing priceLoading daily prices…
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago +6.1%1w ago -1.1%1d ago -1.1%
Returns since7d +0.0%30d +0.2%90d -14.8%180d1y
Transaction facts
Stored Form 4 columns with their raw values
- Type
- grant Code A
- Identifier
- 0001685720-26-000003 Stock Option (Right to Buy)
- Transaction date
- Apr 30, 2026 Filed May 04, 2026, 09:28 PM · 4d delay
- Shares
- 11,296 sh $0.00 per share
- Estimated value
- $0 Computed from shares × price
- Holdings after
- 11,296 sh Direct
Filing signal explanations
Badges describe filing facts only — not predictions.
Cluster 14dRepeat 30dPattern $100kLarge $1.00M
Derivative Transaction Direct Ownership Large Holdings Increase 10b5-1 Detected
Filing-only score
-20 points
Compact filing score computed from stored Form 4 facts. Version v1.
Low filing signal
This filing has a meaningfully negative filing-only score. It is likely less useful as a positive insider-activity signal.
How this score is calculated
- direct_ownership+6 points
direct_or_indirect_ownership = D
Direct ownership reports the insider's personal stake. - derivative_transaction-16 points
is_derivative = true
Derivative exercise rows are less discretionary than open-market purchases. - tenb5_1_detected-10 points
is_10b5_1 = true
Stored filing content includes detected 10b5-1 language.
Signed filing-only points, not a probability or expected return. Version v1.
Reported relationships & other filings
Form 4 relationship flags and nearby filing context
Reported roles
No officer title
Officer NoDirector Yes10% NoOther No
Footnotes & amended
- F1
Represents an annual grant of restricted stock units ("RSUs") granted under the Company's Stock Incentive plan, as amended and restated, for Board and Committee service. Each RSU represents a right to…
- F2
Represents the number of shares sold by the Reporting Person. Shares were sold pursuant to a Rule 10b5-1 trading plan, dated May 16, 2025, for the purpose of satisfying tax obligations relating to the…
- F3
The price reported in Column 4 is a weighted average price for sales executed on the same day within a one-dollar price range. These shares were sold in multiple transactions at prices ranging from $7…
- F4
The price reported in Column 4 is a weighted average price for sales executed on the same day within a one-dollar price range. These shares were sold in multiple transactions at prices ranging from $8…
- F5
Consists of stock options granted under the Company's Stock Incentive Plan, as amended and restated, for Board and Committee service. The shares underlying the options will vest on the Annual Grant Ve…
- F6
The number of options granted was determined by multiplying 25% of the total non-employee director compensation value, and then dividing by the Black-Scholes value of a single option calculated as of…
Related transactions
Same SEC filing0 other transactions
Recent company activity
EBS0 recent txs